TREM2 and Alzheimer disease: TREM2 variants increase the risk of late onset AD by 2–4-fold, and TREM2 is essential to the metabolic shift related to mTOR signaling in inflammatory microglia (Guerreiro et al., 2013; Sims et al., 2017; Ulland and Colonna, 2018).